These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 18388299)

  • 1. Antiviral NK cell responses in HIV infection: II. viral strategies for evasion and lessons for immunotherapy and vaccination.
    Iannello A; Debbeche O; Samarani S; Ahmad A
    J Leukoc Biol; 2008 Jul; 84(1):27-49. PubMed ID: 18388299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiviral NK cell responses in HIV infection: I. NK cell receptor genes as determinants of HIV resistance and progression to AIDS.
    Iannello A; Debbeche O; Samarani S; Ahmad A
    J Leukoc Biol; 2008 Jul; 84(1):1-26. PubMed ID: 18388298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential role of NK cells in the induction of immune responses: implications for NK cell-based immunotherapy for cancers and viral infections.
    Terunuma H; Deng X; Dewan Z; Fujimoto S; Yamamoto N
    Int Rev Immunol; 2008; 27(3):93-110. PubMed ID: 18437601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of NK and NKT cells in the immunopathogenesis of HCV-induced hepatitis.
    Ahmad A; Alvarez F
    J Leukoc Biol; 2004 Oct; 76(4):743-59. PubMed ID: 15218054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NK cells in HIV infection: paradigm for protection or targets for ambush.
    Fauci AS; Mavilio D; Kottilil S
    Nat Rev Immunol; 2005 Nov; 5(11):835-43. PubMed ID: 16239902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted lysis of HIV-infected cells by natural killer cells armed and triggered by a recombinant immunoglobulin fusion protein: implications for immunotherapy.
    Gupta N; Arthos J; Khazanie P; Steenbeke TD; Censoplano NM; Chung EA; Cruz CC; Chaikin MA; Daucher M; Kottilil S; Mavilio D; Schuck P; Sun PD; Rabin RL; Radaev S; Van Ryk D; Cicala C; Fauci AS
    Virology; 2005 Feb; 332(2):491-7. PubMed ID: 15680414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Innate gamma/delta T-cells during HIV infection: Terra relatively Incognita in novel vaccination strategies?
    Agrati C; D'Offizi G; Gougeon ML; Malkovsky M; Sacchi A; Casetti R; Bordoni V; Cimini E; Martini F
    AIDS Rev; 2011; 13(1):3-12. PubMed ID: 21412385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV escape from natural killer cytotoxicity: nef inhibits NKp44L expression on CD4+ T cells.
    Fausther-Bovendo H; Sol-Foulon N; Candotti D; Agut H; Schwartz O; Debré P; Vieillard V
    AIDS; 2009 Jun; 23(9):1077-87. PubMed ID: 19424050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural killer cells, dendritic cells, and the alarmin high-mobility group box 1 protein: a dangerous trio in HIV-1 infection?
    Gougeon ML; Bras M
    Curr Opin HIV AIDS; 2011 Sep; 6(5):364-72. PubMed ID: 21825870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proliferative activation up-regulates expression of CD4 and HIV-1 co-receptors on NK cells and induces their infection with HIV-1.
    Harada H; Goto Y; Ohno T; Suzu S; Okada S
    Eur J Immunol; 2007 Aug; 37(8):2148-55. PubMed ID: 17628860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV's evasion of host's NK cell response and novel ways of its countering and boosting anti-HIV immunity.
    Ahmad A; Ahmad R
    Curr HIV Res; 2003 Jul; 1(3):295-307. PubMed ID: 15046254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-HIV-1 ADCC: clinical and therapeutic implications.
    Weinhold KJ
    Biotechnol Ther; 1991; 2(1-2):147-57. PubMed ID: 1845118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perturbation of natural killer cell function and receptors during HIV infection.
    Eger KA; Unutmaz D
    Trends Microbiol; 2004 Jul; 12(7):301-3. PubMed ID: 15223055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular immunotherapy for cytomegalovirus and HIV-1 infection.
    Van den Bosch GA; Ponsaerts P; Vanham G; Van Bockstaele DR; Berneman ZN; Van Tendeloo VF
    J Immunother; 2006; 29(2):107-21. PubMed ID: 16531812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD56 negative NK cells: origin, function, and role in chronic viral disease.
    Björkström NK; Ljunggren HG; Sandberg JK
    Trends Immunol; 2010 Nov; 31(11):401-6. PubMed ID: 20829113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bovine natural killer cells.
    Boysen P; Storset AK
    Vet Immunol Immunopathol; 2009 Aug; 130(3-4):163-77. PubMed ID: 19339058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NK Cells in HIV Disease.
    Scully E; Alter G
    Curr HIV/AIDS Rep; 2016 Apr; 13(2):85-94. PubMed ID: 27002078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Viral evasion of NK-cell activation.
    Rajagopalan S; Long EO
    Trends Immunol; 2005 Aug; 26(8):403-5. PubMed ID: 15979408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Porcine T lymphocytes and NK cells--an update.
    Gerner W; Käser T; Saalmüller A
    Dev Comp Immunol; 2009 Mar; 33(3):310-20. PubMed ID: 18601948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural Killer cells from long-term non-progressor HIV patients are characterized by altered phenotype and function.
    O'Connor GM; Holmes A; Mulcahy F; Gardiner CM
    Clin Immunol; 2007 Sep; 124(3):277-83. PubMed ID: 17611161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.